Cargando…

The coincidence of IgA nephropathy and Fabry disease

BACKGROUND: IgA nephropathy (IgAN) is the most common glomerulonephritis, which may also coexist with other diseases. We present two patients with an unusual coincidence of IgAN and Fabry disease (FD). CASE PRESENTATION: A 26 year-old man underwent a renal biopsy in February 2001. Histopathology sho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maixnerová, Dita, Tesař, Vladimír, Ryšavá, Romana, Reiterová, Jana, Poupětová, Helena, Dvořáková, Lenka, Goláň, Lubor, Neprašová, Michaela, Kidorová, Jana, Merta, Miroslav, Honsová, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549770/ https://www.ncbi.nlm.nih.gov/pubmed/23305247 http://dx.doi.org/10.1186/1471-2369-14-6

Ejemplares similares

Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

Correction: Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

Emerging Modes of Treatment of IgA Nephropathy
por: Maixnerova, Dita, et al.
Publicado: (2020)

Expanding options of supportive care in IgA nephropathy
por: Maixnerova, Dita, et al.
Publicado: (2023)

Outcome of 313 Czech Patients With IgA Nephropathy After Renal Transplantation
por: Maixnerova, Dita, et al.
Publicado: (2021)

Endotrophin, a collagen type VI-derived matrikine, reflects the degree of renal fibrosis in patients with IgA nephropathy and in patients with ANCA-associated vasculitis
por: Sparding, Nadja, et al.
Publicado: (2021)

Toward Noninvasive Diagnosis of IgA Nephropathy: A Pilot Urinary Metabolomic and Proteomic Study
por: Neprasova, Michaela, et al.
Publicado: (2016)

Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA Nephropathy
por: Neprasova, Michaela, et al.
Publicado: (2023)

Unique Biomarkers of Collagen Type III Remodeling Reflect Different Information Regarding Pathological Kidney Tissue Alterations in Patients with IgA Nephropathy
por: Sparding, Nadja, et al.
Publicado: (2023)

Replacement of α-galactosidase A in Fabry disease: effect on fibroblast cultures compared with biopsied tissues of treated patients
por: Keslová-Veselíková, Jana, et al.
Publicado: (2008)

New Treatment Strategies for IgA Nephropathy: Targeting Plasma Cells as the Main Source of Pathogenic Antibodies
por: Maixnerova, Dita, et al.
Publicado: (2022)

Urine proteomics for prediction of disease progression in patients with IgA nephropathy
por: Rudnicki, Michael, et al.
Publicado: (2020)

Mutational screening of inverted formin 2 in adult-onset focal segmental glomerulosclerosis or minimal change patients from the Czech Republic
por: Safarikova, Marketa, et al.
Publicado: (2018)

Novel mutations of PKD genes in the Czech population with autosomal dominant polycystic kidney disease
por: Obeidova, Lena, et al.
Publicado: (2014)

Autosomal dominant polycystic kidney disease in a family with mosaicism and hypomorphic allele
por: Reiterová, Jana, et al.
Publicado: (2013)

Bilineal inheritance of pathogenic PKD1 and PKD2 variants in a Czech family with autosomal dominant polycystic kidney disease – a case report
por: Elisakova, Veronika, et al.
Publicado: (2018)

Autosomal Dominant Polycystic Kidney Disease: From Pathophysiology of Cystogenesis to Advances in the Treatment
por: Reiterová, Jana, et al.
Publicado: (2022)

Current and Future Therapeutical Options in Alport Syndrome
por: Reiterová, Jana, et al.
Publicado: (2023)

The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations
por: Poupětová, Helena, et al.
Publicado: (2010)

Coincidental finding of Fabry’s disease in a patient with IgA nephropathy
por: Kakita, Tomoko, et al.
Publicado: (2010)

Is there a pathogenic association between Fabry’s disease and IgA nephropathy?
por: Fujinaga, Shuichiro, et al.
Publicado: (2013)

Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease
por: Rob, Daniel, et al.
Publicado: (2016)

Correction: Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease
por: Rob, Daniel, et al.
Publicado: (2017)

Serum Bilirubin Levels and Promoter Variations in HMOX1 and UGT1A1 Genes in Patients with Fabry Disease
por: Jirásková, Alena, et al.
Publicado: (2017)

IgA nephropathy with mimicking Fabry disease: A case report and literature review
por: Sun, Liping, et al.
Publicado: (2022)

Challenges in IgA Nephropathy Management: An Era of Complement Inhibition
por: Tesař, Vladimir, et al.
Publicado: (2023)

New mutations in the PKD1 gene in Czech population with autosomal dominant polycystic kidney disease
por: Stekrova, Jitka, et al.
Publicado: (2009)

IgA nephropathy suspected to be combined with Fabry disease or Alport syndrome: a case report
por: Hao, Wen, et al.
Publicado: (2019)

Biomarkers of fibrosis, kidney tissue injury and inflammation may predict severity and outcome of renal ANCA – associated vasculitis
por: Satrapova, Veronika, et al.
Publicado: (2023)

Why Target the Gut to Treat IgA Nephropathy?
por: Barratt, Jonathan, et al.
Publicado: (2020)

Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-up
por: Pesickova, Satu Sinikka, et al.
Publicado: (2015)

Fabry nephropathy: a review – how can we optimize the management of Fabry nephropathy?
por: Waldek, Stephen, et al.
Publicado: (2014)

Intrarenal Complement System Transcripts in Chronic Antibody-Mediated Rejection and Recurrent IgA Nephropathy in Kidney Transplantation
por: Cernoch, Marek, et al.
Publicado: (2018)

Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments
por: Coppo, Rosanna, et al.
Publicado: (2014)

Ventricular tachycardia: a presentation of Fabry disease case report
por: Pavlu, Ludek, et al.
Publicado: (2018)

International Physicians Delphi Survey: Managing Patients With IgA Nephropathy
por: Floege, Jürgen, et al.
Publicado: (2022)

Observational, retrospective study of a large cohort of patients with Niemann-Pick disease type C in the Czech Republic: a surprisingly stable diagnostic rate spanning almost 40 years
por: Jahnova, Helena, et al.
Publicado: (2014)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Biomarkers of Fabry Nephropathy: Review and Future Perspective
por: Levstek, Tina, et al.
Publicado: (2020)

Treatment of Fabry Nephropathy: A Literature Review
por: Shimohata, Homare, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_keji5s56bvrous13oedjvomde6